Why the study?
Glutaraldehyde-crosslinked pericardium in bioprosthetic valves has persistent issues with glutaraldehyde residue and calcification, motivating non-glutaraldehyde-crosslinked dry valve strategies.
Does EDC and curcumin crosslinking improve material properties and reduce calcification of pericardial tissue compared to glutaraldehyde crosslinking in preclinical models?
Does EDC and curcumin crosslinking improve material properties and reduce calcification of pericardial tissue compared to glutaraldehyde crosslinking in preclinical models?
EDC and curcumin crosslinking of pericardial tissue yields superior anti-calcification and material properties compared to traditional glutaraldehyde crosslinking, offering a promising strategy for dry bioprosthetic valves.
Answers are grounded in this paper and cite their sources.
EDC-polyphenol crosslinking yields viable dry valve material; hypothesis-generating for reduced calcification, pending clinical trials.
The glutaraldehyde crosslinked pericardium has been used in bioprosthetic valves for about 50 years. However, problems such as glutaraldehyde residue and calcification still exist in current commercial products. Non-glutaraldehyde crosslinked dry valve is an important strategy to solve those problems. In this study, a non-glutaraldehyde crosslinked dry biological valve material was obtained by the combined crosslinking of carbodiimide (EDC) and polyphenol. The results showed that the comprehensive properties of EDC and curcumin crosslinked pericardium were superior to glutaraldehyde crosslinked pericardium, including unfolding property, anti-calcification, cytotoxicity, anticoagulant properties, mechanical properties, enzyme degradation resistance and thermal shrinkage temperature. EDC and curcumin crosslinked dry pericardium could flatten after being folded at 40°C for 3 days while glutaraldehyde crosslinked pericardium could not. The calcification of pericardium treated with EDC and curcumin was 1.21 ± 0.36 mg/g in rats after 60 days' subdermal implantation, much lower than that of glutaraldehyde treated control group (22.06 ± 3.17 mg/g).
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: